Stockreport

ResMed (NYSE:RMD) Exceeds Q4 CY2025 Expectations [Yahoo! Finance]

ResMed Inc.  (RMD) 
Last resmed inc. earnings: 4/30 04:05 pm Check Earnings Report
PDF Its non-GAAP profit of $2.81 per share was 3.2% above analysts' consensus estimates. Is now the time to buy ResMed? Find out in our full research report Revenue: $1. [Read more]